Clinical Trial Update: Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic [NA]

View source ↗

Summary

A clinical trial evaluating how a multispecies synbiotic alters gut-derived uremic toxins and microbiome metabolites; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Multispecies Synbiotic

Snippet

Sponsor: Tungs' Taichung Metroharbour Hospital | Conditions: Symbiotic, Uremic Toxins | NA | Status: NOT_YET_RECRUITING